Nasogastric Tube Market Analysis

  • Report ID: 5016
  • Published Date: May 09, 2025
  • Report Format: PDF, PPT

Nasogastric Tube Segmentation

Indication (Dysphagia, IBD, Unconsciousness, Neck & Head Cancer, Malnutrition)

The dysphagia segment is estimated to hold over 45% share of the global nasogastric tube market by 2037. Moreover, the segment was responsible for around 21% of the total market portion in 2022. Dysphagia is the weakening and destruction of the nerves and muscles that are required for swelling. The primary cause of dysphagia is stroke, head injury, dementia, and others. Every year, in the world 15 million people are affected by a stroke. 5 million of these people die, and another 5 million are chronically crippled. Due to dysphagia, the risk of malnutrition and dehydration. Nasogastric tubes can provide a means to deliver clinical nutrition directly into the stomach, ensuring the patient is meeting their dietary requirement.

Tube (Levin Catheter, Dobhoff Tube, Sengstaken-Blakemore Tube)

The levin catheter segment in the nasogastric tube market is expected to garner a significant proportion of around 46% in the year 2037. The growth of the segment is credited to the higher adoption of Levin tubes, which has an open tip and only a single lumen. Furthermore, improved access to healthcare services, particularly in developing regions, can contribute to an increased demand for medical procedures that necessitate the use of Levin catheters.

Our in-depth analysis of the global nasogastric tube market includes the following segments:

        Tube

  • Levin Catheter
  • Dobhoff Tube
  • Sengstaken-Blakemore Tube

         Patient Group

  • Adult
  • Geriatric

        Indication

  • Dysphagia
  • IBD
  • Unconsciousness
  • Neck & Head Cancer
  • Malnutrition

         End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

Nasogastric Tube Market in 2025 is evaluated at USD 586.26 million.

The global market size was over USD 561.98 million in 2024 and is anticipated to witness a CAGR of around 5.4%, crossing USD 1.11 billion revenue by 2037.

North America is estimated to generate USD 432.9 million by 2037, fueled by development of various supportive regulatory guidelines and increasing demand from chronic diseases.

The major players in the market include Becton, Dickinson and Company, QMD, Angiplast Pvt. Ltd., Securmed, Vygon SAS, Medtronic, Andersen Products Ltd., Cardinal Health, Baihe Medical, Poly Medicure Limited.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos